1-2 of 2
Clémentine Joubert, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

PET-Guided Strategy Improves the Safety of Beacopp-Based Treatment in Advanced Hodgkin Lymphoma: Prolonged Follow-up of the Lysa Ahl 2011 Phase 3 Study

Olivier Casasnovas, MD, Judith Racape, MD, Julie Dechene, Reda Bouabdallah, MD, Pauline Brice, MD, Julien Lazarovici, MD, Hervé Ghesquieres, MD PhD, Aspasia Stamatoulas Bastard, MD, Jehan Dupuis, MD, Anne-Claire Gac, MD, Thomas Gastinne, MD, Bertrand Joly, MD, Krimo Bouabdallah, MD, Emmanuelle Nicolas-Virelizier, MD, Pierre Feugier, MD, Franck Morschhauser, MD PhD, Marc André, MD, Alina Berriolo-Riedinger, MD, Veronique Edeline, MD, Clémentine Joubert, PhD, Michel Meignan, MD, Isabelle Demeestere, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 23–24.
https://doi.org/10.1182/blood-2020-136056
Published: 2020
Journal Articles

Stage IIb High Risk Hodgkin Lymphoma Treated in the H10 and AHL2011 Trials: Similar Efficacy of Both Strategies and Prognostic Impact of Baseline Tmtv and PET2 Response

Cédric Rossi, MD PhD, Marc André, Clémentine Joubert, PhD, Catherine Fortpied, Pauline Brice, Bénédicte Deau-Fisher, MD, Herve Ghesquieres, MD PhD, Luc Mathieu Fornecker, MD PhD, Anne-Claire Gac, MD, Julien Lazarovici, Aspasia Stamatoullas, MD, John Raemakers, Massimo Federico, MD, Marie Maerevoet, MD, Sarah Bailly, MD, Salim Kanoun, MD, Michel Meignan, Anne Ségolène Cottereau, Rene-Olivier Casasnovas, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 128.
https://doi.org/10.1182/blood-2019-125976
Published: 2019